Zhengye Biotechnology Holding Limited (ZYBT)
NASDAQ: ZYBT · Real-Time Price · USD
4.280
-0.050 (-1.15%)
Feb 11, 2025, 2:24 PM EST - Market open
ZYBT Income Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
TTM
| FY 2023 | FY 2022 | FY 2021 |
Jun '24 Jun 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Revenue | 189.75 | 211.65 | 260.27 | 214.07 |
Revenue Growth (YoY) | -25.23% | -18.68% | 21.58% | - |
Cost of Revenue | 84.42 | 91.84 | 107.27 | 89.45 |
Gross Profit | 105.33 | 119.81 | 153 | 124.62 |
Selling, General & Admin | 66.91 | 66.63 | 63.56 | 58.86 |
Research & Development | 11.19 | 11.9 | 13.42 | 11.37 |
Operating Expenses | 74.75 | 74.82 | 86.72 | 72.16 |
Operating Income | 30.58 | 44.99 | 66.28 | 52.47 |
Interest Expense | -4.32 | -4.42 | -2.84 | -1.05 |
Interest & Investment Income | 0.42 | 0.31 | 0.11 | 0.11 |
Other Non Operating Income (Expenses) | 3.05 | 2.89 | 0.81 | 1.62 |
EBT Excluding Unusual Items | 29.72 | 43.76 | 64.36 | 53.15 |
Asset Writedown | - | - | -0.45 | -0.08 |
Pretax Income | 29.72 | 43.76 | 63.91 | 53.07 |
Income Tax Expense | 5.56 | 6.25 | 8.17 | 6.6 |
Earnings From Continuing Operations | 24.16 | 37.51 | 55.74 | 46.47 |
Minority Interest in Earnings | -3.88 | -6.05 | -9.01 | -7.51 |
Net Income | 20.29 | 31.46 | 46.74 | 38.96 |
Net Income to Common | 20.29 | 31.46 | 46.74 | 38.96 |
Net Income Growth | -53.70% | -32.69% | 19.96% | - |
Shares Outstanding (Basic) | 46 | 46 | 46 | 46 |
Shares Outstanding (Diluted) | 46 | 46 | 46 | 46 |
EPS (Basic) | 0.44 | 0.69 | 1.02 | 0.85 |
EPS (Diluted) | 0.44 | 0.69 | 1.02 | 0.85 |
EPS Growth | -53.70% | -32.69% | 19.96% | - |
Free Cash Flow | 46.9 | 40.79 | -9.99 | 12.75 |
Free Cash Flow Per Share | 1.03 | 0.89 | -0.22 | 0.28 |
Gross Margin | 55.51% | 56.61% | 58.78% | 58.22% |
Operating Margin | 16.11% | 21.25% | 25.47% | 24.51% |
Profit Margin | 10.69% | 14.86% | 17.96% | 18.20% |
Free Cash Flow Margin | 24.72% | 19.27% | -3.84% | 5.95% |
EBITDA | 53.9 | 68.9 | 85.08 | 68.48 |
EBITDA Margin | 28.41% | 32.55% | 32.69% | 31.99% |
D&A For EBITDA | 23.32 | 23.91 | 18.8 | 16.01 |
EBIT | 30.58 | 44.99 | 66.28 | 52.47 |
EBIT Margin | 16.11% | 21.25% | 25.47% | 24.51% |
Effective Tax Rate | 18.69% | 14.29% | 12.79% | 12.44% |
Advertising Expenses | - | 2.54 | 2.58 | 2.23 |
Source: S&P Capital IQ. Standard template.
Financial Sources.